AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
ALPELISIB
19 registrations across 4 African markets— 19 active
Markets with ALPELISIB
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| PIVIKTO 200MG/50MG COMPRIME PELLICULE BOITE DE 14-14 | 🇨🇮Côte d'Ivoire | NOVARTIS PHARMA AG, LICHTSTRASSE 35, CH-4056 BALESUISSE | active | Mar 2029 |
| Pivikto 150 mg Film Coated Tablet** Tablet | 🇳🇬Nigeria | Novartis Nigeria Limited | active | Aug 2028 |
| Pivikto 200 mg Film Coated Tablet** Tablet | 🇳🇬Nigeria | Novartis Nigeria Limited | active | Aug 2028 |
| Pivikto 50 mg Film Coated Tablets** Tablet | 🇳🇬Nigeria | Novartis Nigeria Limited | active | Aug 2028 |
| PIVIKTO 50 mg | 🇿🇦South Africa | Novartis South Africa (Pty) Ltd | active | Jan 1900 |
| PIVIKTO 150 mg | 🇿🇦South Africa | Novartis South Africa (Pty) Ltd | active | Jan 1900 |
| PIVIKTO 200 mg | 🇿🇦South Africa | Novartis South Africa (Pty) Ltd | active | Jan 1900 |
| PIVIKTO 200MG COMPRIME PELLICULE BOITE DE 14 | 🇨🇮Côte d'Ivoire | NOVARTIS PHARMA AG, LICHTSTRASSE 35, CH-4056 BÂLE – SUISSE | active | — |
| PIVIKTO 150MG COMPRIME PELLICULE BOITE DE 56 | 🇨🇮Côte d'Ivoire | NOVARTIS PHARMA AG | active | — |
| PIVIKTO comprimé pelliculé / 200 mg + 50 mg | 🇸🇳Senegal | NOVARTIS | active | — |
| PIVIKTO 200MG COMPRIME PELLICULE BOITE DE 28 | 🇨🇮Côte d'Ivoire | NOVARTIS PHARMA AG | active | — |
| PIVIKTO 200MG/50MG COMPRIME PELLICULE BOÎTE DE 14/14 | 🇨🇮Côte d'Ivoire | NOVARTIS PHARMA AG | active | — |
| PIVIKTO comprimé pelliculé / 150 mg | 🇸🇳Senegal | NOVARTIS | active | — |
| PIVIKTO 200MG/50MG COMPRIME PELLICULE BOÎTE DE 28/28 | 🇨🇮Côte d'Ivoire | NOVARTIS PHARMA AG, LICHTSTRASSE 35, CH-4056 BÂLE – SUISSE | active | — |
| PIVIKTO 150MG COMPRIME PELLICULE BOITE DE 28 | 🇨🇮Côte d'Ivoire | NOVARTIS PHARMA AG | active | — |
| PIVIKTO comprimé pelliculé / 150 mg | 🇸🇳Senegal | NOVARTIS | active | — |
| PIVIKTO comprimé pelliculé / 200 mg + 50 mg | 🇸🇳Senegal | NOVARTIS | active | — |
| PIVIKTO comprimé pelliculé / 200 mg | 🇸🇳Senegal | NOVARTIS | active | — |
| PIVIKTO comprimé pelliculé / 200 mg | 🇸🇳Senegal | NOVARTIS | active | — |
ALPELISIB in Africa — Regulatory Overview
ALPELISIB is registered across 4 African markets with 19 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Côte d'Ivoire, Senegal, Nigeria, South Africa. AfricaRegulatory refreshes this data daily from official government sources.
Of the 19 registrations, 19 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.